Read more at CNBC.
Amgen scraps experimental weight loss pill, moves forward with injection
Date: |
Topics
Sort by
Filter
Date
Items per page
-
Rock band Cage the Elephant emerge from loss and hospitalization with new album 'Neon Pill'
To say Cage the Elephant’s latest album had a turbulent birth would be an understatementABC News - Entertainment -
Roche says weight loss drug shows promising results in early trial
The weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after 24 weeks in the phase one trial.CNBC - Business -
Roche Climbs After Weight-Loss Drug Shows Efficacy
Roche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial, giving the company a boost in its bid to catch up to Novo Nordisk and Eli Lilly in a class of medicines that has shaken up everything from pharma ...The Wall Street Journal - Business -
Justice Department moves forward with easing restrictions on marijuana
The Justice Department officially proposed a new rule on Thursday that would reclassify marijuana as a Schedule III drug.CBS News - Top stories
More from CNBC
-
GameStop shares fall 20% after it files to sell additional stock, says first quarter sales dropped
GameStop said it plans to sell securities and reported preliminary results that showed a sales decline in the first quarter.CNBC - Business -
AI infrastructure startup CoreWeave raises $7.5 billion in debt deal led by Blackstone
CoreWeave's $7.5 billion debt financing follows a $1.1 billion funding round the startup announced two weeks ago.CNBC - Business -
Latest shipping data reveals that mid-range retail is the new consumer price sweet spot
Retailers are converging on 'middle-price-point' items as the best way to reach consumers, a new CNBC Supply Chain Survey shows.CNBC - Business -
After Adobe collapse, Figma deal allows employees to sell shares at $12.5 billion valuation
Figma on Thursday announced a tender offer that will allow current and former employees to sell shares at a valuation of $12.5 billion.CNBC - Business -
Shares of Cartier owner Richemont climb on record full-year sales, new CEO
Shares of Swiss luxury group Richemont climbed as much as 6.3% Friday after it reported record full-year sales even as Asia Pacific spending waned.CNBC - Business